Wiersinga WJ - Search Results

1

Therapeutic Potential of the Gut Microbiota in the Prevention and Treatment of Sepsis.

Haak BW, Prescott HC, Wiersinga WJ. Haak BW, et al. Among authors: wiersinga wj. Front Immunol. 2018 Sep 10;9:2042. doi: 10.3389/fimmu.2018.02042. eCollection 2018. Front Immunol. 2018. PMID: 30250472 Free PMC article. Review.

2

[Sepsis: new insights into its pathogenesis and treatment].

Wiersinga WJ, van der Poll T. Wiersinga WJ, et al. Ned Tijdschr Geneeskd. 2010;154:A1130. Ned Tijdschr Geneeskd. 2010. PMID: 20170566 Review. Dutch.

3

The intestinal microbiota and host immune interactions in the critically ill.

Schuijt TJ, van der Poll T, de Vos WM, Wiersinga WJ. Schuijt TJ, et al. Among authors: wiersinga wj. Trends Microbiol. 2013 May;21(5):221-9. doi: 10.1016/j.tim.2013.02.001. Epub 2013 Feb 28. Trends Microbiol. 2013. PMID: 23454077 Review.

4

[The gut microbiota in sickness and health].

Lankelma JM, Nieuwdorp M, de Vos WM, Wiersinga WJ. Lankelma JM, et al. Among authors: wiersinga wj. Ned Tijdschr Geneeskd. 2014;157:A5901. Ned Tijdschr Geneeskd. 2014. PMID: 24780568 Review. Dutch.

5

The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia.

Schuijt TJ, Lankelma JM, Scicluna BP, de Sousa e Melo F, Roelofs JJ, de Boer JD, Hoogendijk AJ, de Beer R, de Vos A, Belzer C, de Vos WM, van der Poll T, Wiersinga WJ. Schuijt TJ, et al. Among authors: wiersinga wj. Gut. 2016 Apr;65(4):575-83. doi: 10.1136/gutjnl-2015-309728. Epub 2015 Oct 28. Gut. 2016. PMID: 26511795 Free PMC article.

6

Antibiotic-induced gut microbiota disruption during human endotoxemia: a randomised controlled study.

Lankelma JM, Cranendonk DR, Belzer C, de Vos AF, de Vos WM, van der Poll T, Wiersinga WJ. Lankelma JM, et al. Among authors: wiersinga wj. Gut. 2017 Sep;66(9):1623-1630. doi: 10.1136/gutjnl-2016-312132. Epub 2016 Jun 15. Gut. 2017. PMID: 27307305 Clinical Trial.

7

Critically ill patients demonstrate large interpersonal variation in intestinal microbiota dysregulation: a pilot study.

Lankelma JM, van Vught LA, Belzer C, Schultz MJ, van der Poll T, de Vos WM, Wiersinga WJ. Lankelma JM, et al. Among authors: wiersinga wj. Intensive Care Med. 2017 Jan;43(1):59-68. doi: 10.1007/s00134-016-4613-z. Epub 2016 Nov 11. Intensive Care Med. 2017. PMID: 27837233 Free PMC article.

8

Microbiota-targeted therapies on the intensive care unit.

Haak BW, Levi M, Wiersinga WJ. Haak BW, et al. Among authors: wiersinga wj. Curr Opin Crit Care. 2017 Apr;23(2):167-174. doi: 10.1097/MCC.0000000000000389. Curr Opin Crit Care. 2017. PMID: 28092309 Review.

9

Rapid DNA vaccination against Burkholderia pseudomallei flagellin by tattoo or intranasal application.

Lankelma JM, Wagemakers A, Birnie E, Haak BW, Trentelman JJA, Weehuizen TAF, Ersöz J, Roelofs JJTH, Hovius JW, Wiersinga WJ, Bins AD. Lankelma JM, et al. Among authors: wiersinga wj. Virulence. 2017 Nov 17;8(8):1683-1694. doi: 10.1080/21505594.2017.1307485. Epub 2017 Apr 19. Virulence. 2017. PMID: 28323523 Free PMC article.

10

The role of the gut microbiota in sepsis.

Haak BW, Wiersinga WJ. Haak BW, et al. Among authors: wiersinga wj. Lancet Gastroenterol Hepatol. 2017 Feb;2(2):135-143. doi: 10.1016/S2468-1253(16)30119-4. Epub 2017 Jan 12. Lancet Gastroenterol Hepatol. 2017. PMID: 28403983 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

310 results

Search Page